Manufacturers Life Insurance Company, The Maxcyte, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Maxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 40,498 shares of MXCT stock, worth $110,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,498
Previous 41,037
1.31%
Holding current value
$110,559
Previous $159,000
5.66%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$25.5 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$22.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$14.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$13.8 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$12 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $278M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...